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Plaque-Reduction Neutralization Assay 
 
Serum samples were assayed for West Nile virus (WNV)–specific antibodies by using the 
plaque-reduction neutralization test as previously described (1). Briefly, each serum sample was 
diluted 1:5 in BA1 and mixed with an equal volume of BA1 containing a suspension of WNV 
NY99-4132 at a concentration of approximately 200 PFU/0.1 mL, such that the final serum 
dilution was 1:10 and the final concentration of WNV was approximately 100 PFU/0.1 mL. For 
the postinoculation serum samples, we also tested serial twofold dilutions of serum to determine 
endpoint 90%-neutralization titers. In most cases, preinoculation serum samples were tested for 
neutralizing antibodies to St. Louis encephalitis virus, a closely related flavivirus that may cross-
react serologically with WNV (2) and may partially protect against WNV infection (3). After 1 h 
incubation at 37°C, 5% CO2, virus-serum mixtures were assayed for virus content by plaque 
assay (see above). Controls used included BA1 only (cell viability control), bird serum-free virus 
mixture with BA1 only (to enumerate the number of PFU in the challenge dose of virus), and 
WNV hyperimmune mouse ascitic fluid (diluted 1:200) mixture with virus (positive control, to 
verify challenge virus identity).  
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